miR-26a as a novel potential therapeutic via inhibit CD38 translation in multiple myeloma

Jianjun Zhao; Yi Hu; Huimin Liu; Chuanfeng Fang; Chen Li; Fjorela Xhyliu; Jaroslaw Maciejewski; Wenjun Li; Geyou Ao; Jianhong Lin; Qing Yi; Nikhil Munshi

miR-26a as a novel potential therapeutic via inhibit CD38 translation in multiple myeloma

Jianjun Zhao
, Yi Hu
, Huimin Liu
, Chuanfeng Fang
, Chen Li
, Fjorela Xhyliu
, Jaroslaw Maciejewski
, Wenjun Li
, Geyou Ao
, Jianhong Lin
, Qing Yi
, Nikhil Munshi

Chemical and Biomedical Engineering

Research output: Contribution to journal › Article

Original language	English
Journal	Cancer Research
State	Published - 2019

Cite this

@article{0ef479487e804f0783475c12fb37a8f8,

title = "miR-26a as a novel potential therapeutic via inhibit CD38 translation in multiple myeloma",

author = "Jianjun Zhao and Yi Hu and Huimin Liu and Chuanfeng Fang and Chen Li and Fjorela Xhyliu and Jaroslaw Maciejewski and Wenjun Li and Geyou Ao and Jianhong Lin and Qing Yi and Nikhil Munshi",

year = "2019",

language = "English",

journal = "Cancer Research",

}

TY - JOUR

T1 - miR-26a as a novel potential therapeutic via inhibit CD38 translation in multiple myeloma

AU - Zhao, Jianjun

AU - Hu, Yi

AU - Liu, Huimin

AU - Fang, Chuanfeng

AU - Li, Chen

AU - Xhyliu, Fjorela

AU - Maciejewski, Jaroslaw

AU - Li, Wenjun

AU - Ao, Geyou

AU - Lin, Jianhong

AU - Yi, Qing

AU - Munshi, Nikhil

PY - 2019

Y1 - 2019

M3 - Article

JO - Cancer Research

JF - Cancer Research

ER -